Slingshot members are tracking this event:

DBV Technologies (DBVT) Initiates Phase III Trial Evaluating Viaskin Peanut in Children with Peanut Allergies

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 07, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase Iii Initiation, Pepites Trial, Children With Peanut Allergies, Viaskin Peanut